Prevalence of Gastrointestinal Symptoms in Opioid Consumers Referring to Methadone Maintenance Treatment (MMT) Clinics in Isfahan, Iran

Document Type : Original Article (s)

Authors

1 Student of Medicine, Psychosomatic Research Center AND Behavioral Sciences Research Center AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associate Professor, Psychosomatic Research Center AND Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Behavioral Sciences Research Center AND Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 General Practitioner, Psychosomatic Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

5 Professor, Department of Gastroenterology, School of Medicine AND Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Mental and physiological responses to the repeated use of drugs are called dependency. Opioid bowel dysfunction (OBD) is common side effect associated with opium. OBD has many manifestations such as abdominal pain, abdominal cramping, bloating and gastroesophageal reflux but is known commonly by constipation. Narcotic bowel syndrome (NBS) is a subset of OBD characterized by recurrent and chronic abdominal pain getting worse by continuing or increasing doses of opium. Due to ever increasing incidence of consumption of narcotics drugs and also expanded spread of gastrointestinal disorders in people of society and due to lack of precise studies in such cases in Iran, research in this field seemed vital.Methods: In this cross-sectional study, among all methadone maintenance therapy (MMT) clinics in Isfahan, Iran, 4 centers were selected by easy non-probability sampling method in 2012 fall. A questionnaire was distributed among the opioid consumers. The questionnaire contained demographic information sucs as age, sex, occupation, and duration of drug use, drug type, duration of MMT, gastrointestinal symptoms and the severity of the symptoms.Findings: From 192 completed and collected questionnaires, 184 were acceptable. The most common gastrointestinal symptoms in patients were constipation, abdominal pain, belching and bad taste in the mouth, respectively. The severity of symptoms and extent of methadone use in patients were assessed and gastrointestinal symptoms were not associated significantly with methadone dose of patients.Conclusion: In this study, the prevalence of gastrointestinal symptoms among patients in addiction clinics was assessed and the most common digestive complaint of these patients was constipation. Severity of constipation and other gastrointestinal symptoms were unrelated with amount of methadone use and the type and amount of prior drug use.

Keywords

References

  1. Lemonick M. How we get addicted. Time 2007; 170(3): 1-7.
  2. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363(21): 1981-5.
  3. McNicol ED, Boyce D, Schumann R, Carr DB. Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev 2008; (2): CD006332.
  4. Mitra S. Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag 2008; 4(3): 123-30.
  5. Farhodian A, Sadrossadat SJ, Mohammadi F, Manokyan A, Jafari F, Sadeghi M, et al. Evaluated knowledge and attitudes of a group of Armenians in Tehran and drug addiction. Adv Cogn Sci 2008; 10(2): 9-20. [In Persian].
  6. Maleki FH. Close road of addiction in Iran. Ebtekar Newspaper 2007 Dec 6. [In Persian].
  7. Javadi RKh. Identity and relationship addiction in women in Tehran province. Rssearch on Addiction 2008; 2(7): 55-66. [In Persian].
  8. Hassan Shahi MM, Ahmadian K. Study of mental health drugs, mental battalion dependent patients. J Fundam Ment Health 2005; 6(23-24): 131-9. [In Persian].
  9. Nourani Poor R. Studying the factors in dependency to substances changing the mood and behavior and effective methods in drug addiction counseling. Rssearch on Addiction 2004; 2(6): 13-54. [In Persian].
  10. Doyle D, Hanks G, Cherny N, Calman K. 3rd ed. Oxford, UK: Oxford University Press; 2005.
  11. Vella-Brincat J, Macleod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007; 21(1): 15-25.
  12. Manzke T, Guenther U, Ponimaskin EG, Haller M, Dutschmann M, Schwarzacher S, et al. 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 2003; 301(5630): 226-9.
  13. Diaz JL, Zamanillo D, Corbera J, Baeyens JM, Maldonado R, Pericas MA, et al. Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 2009; 9(3): 172-83.
  14. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001; 182(5A Suppl): 11S-8S.
  15. Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007; 5(10): 1126-39.
  16. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2009; 10(1): 35-42.
  17. Rosti G, Gatti A, Costantini A, Sabato AF, Zucco F. Opioid-related bowel dysfunction: prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment. Eur Rev Med Pharmacol Sci 2010; 14(12): 1045-50.
  18. Langrod J, Lowinson J, Ruiz P. Methadone treatment and physical complaints: a clinical analysis. Int J Addict 1981; 16(5): 947-52.
  19. Gray D, Des S. The prevalence of constipation in patients receiving methadone maintenance treatment for opioid dependency. J Subst Use 2005; 10(6): 397-401.
  20. Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet 2009; 373(9670): 1198-206.
Journal of Isfahan Medical School
Volume 31, Issue 240 - Serial Number 240
May and June 2013
Pages 843-850

Files

History

  • Receive Date: 24 June 2013
  • Revise Date: 07 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics